Showing codes J9051 (Injection, bortezomib (maia), not therapeutically equivalent to j9041, 0.1 mg) — J9153 (Injection, liposomal, 1 mg daunorubicin and 2.27 mg cytarabine)

J9051 - Inj, bortezomib (maia)
Long description: Injection, bortezomib (maia), not therapeutically equivalent to j9041, 0.1 mg
Code added date: 20231001.
Code effective date: 20231001.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: C (A code denoting Medicare coverage status).
HTML    PDF

J9052 - Inj, carmustine (accord)
Long description: Injection, carmustine (accord), not therapeutically equivalent to j9050, 100 mg
Code added date: 20240101.
Code effective date: 20240101.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF

J9054 - Inj bortezomib boruzu 0.1 mg
Long description: Injection, bortezomib (boruzu), 0.1 mg
Code added date: 20250401.
Code effective date: 20250401.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: C (A code denoting Medicare coverage status).
HTML    PDF

J9055 - Cetuximab injection
Long description: Injection, cetuximab, 10 mg
Code added date: 20050101.
Code effective date: 20050101.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: C (A code denoting Medicare coverage status).
HTML    PDF

J9056 - Inj, vivimusta, 1 mg
Long description: Injection, bendamustine hydrochloride (vivimusta), 1 mg
Code added date: 20230701.
Code effective date: 20250101.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: C (A code denoting Medicare coverage status).
HTML    PDF

J9057 - Inj., copanlisib, 1 mg
Long description: Injection, copanlisib, 1 mg
Code added date: 20190101.
Code effective date: 20190101.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: C (A code denoting Medicare coverage status).
HTML    PDF

J9058 - Inj apotex/bendamustine 1 mg
Long description: Injection, bendamustine hydrochloride (apotex), 1 mg
Code added date: 20230701.
Code effective date: 20250101.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: C (A code denoting Medicare coverage status).
HTML    PDF

J9059 - Inj bendamustine, baxter 1mg
Long description: Injection, bendamustine hydrochloride (baxter), 1 mg
Code added date: 20230701.
Code effective date: 20250101.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: C (A code denoting Medicare coverage status).
HTML    PDF

J9060 - Cisplatin 10 mg injection
Long description: Injection, cisplatin, powder or solution, 10 mg
Code added date: 19840101.
Code effective date: 20110101.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF

J9061 - Inj, amivantamab-vmjw
Long description: Injection, amivantamab-vmjw, 2 mg
Code added date: 20220101.
Code effective date: 20220101.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: C (A code denoting Medicare coverage status).
HTML    PDF

J9063 - Inj, elahere, 1 mg
Long description: Injection, mirvetuximab soravtansine-gynx, 1 mg
Code added date: 20230701.
Code effective date: 20230701.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: C (A code denoting Medicare coverage status).
HTML    PDF

J9064 - Inj, cabazitaxel (sandoz)
Long description: Injection, cabazitaxel (sandoz), not therapeutically equivalent to j9043, 1 mg
Code added date: 20231001.
Code effective date: 20231001.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: C (A code denoting Medicare coverage status).
HTML    PDF

J9065 - Inj cladribine per 1 mg
Long description: Injection, cladribine, per 1 mg
Code added date: 19950101.
Code effective date: 19970101.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF

J9070 - Cyclophosphamide 100 mg inj
Long description: Cyclophosphamide, 100 mg
Code added date: 19840101.
Code effective date: 20240401.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF

J9071 - Inj cyclophosphamd auromedic
Long description: Injection, cyclophosphamide (auromedics), 5 mg
Code added date: 20220401.
Code effective date: 20240401.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF

J9072 - Inj cyclophos frindovyx 5 mg
Long description: Injection, cyclophosphamide (frindovyx), 5 mg
Code added date: 20240101.
Code effective date: 20251001.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF

J9073 - Inj cyclophos dr reddys 5 mg
Long description: Injection, cyclophosphamide (dr. reddy's), 5 mg
Code added date: 20240401.
Code effective date: 20250401.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF

J9074 - Inj, cyclophosphamd, sandoz
Long description: Injection, cyclophosphamide (sandoz), 5 mg
Code added date: 20240401.
Code effective date: 20240401.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF

J9075 - Inj, cyclophosphamide, nos
Long description: Injection, cyclophosphamide, not otherwise specified, 5 mg
Code added date: 20240401.
Code effective date: 20240401.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF

J9076 - Inj, cyclophos (baxter) 5mg
Long description: Injection, cyclophosphamide (baxter), 5 mg
Code added date: 20250101.
Code effective date: 20250101.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF

J9098 - Cytarabine liposome inj
Long description: Injection, cytarabine liposome, 10 mg
Code added date: 20040101.
Code effective date: 20260101.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: C (A code denoting Medicare coverage status).
HTML    PDF

J9100 - Cytarabine hcl 100 mg inj
Long description: Injection, cytarabine, 100 mg
Code added date: 19860101.
Code effective date: 20090101.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF

J9118 - Inj. calaspargase pegol-mknl
Long description: Injection, calaspargase pegol-mknl, 10 units
Code added date: 20191001.
Code effective date: 20191001.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: C (A code denoting Medicare coverage status).
HTML    PDF

J9119 - Inj., cemiplimab-rwlc, 1 mg
Long description: Injection, cemiplimab-rwlc, 1 mg
Code added date: 20191001.
Code effective date: 20191001.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: C (A code denoting Medicare coverage status).
HTML    PDF

J9120 - Dactinomycin injection
Long description: Injection, dactinomycin, 0.5 mg
Code added date: 19840101.
Code effective date: 20090101.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF

J9130 - Dacarbazine 100 mg inj
Long description: Dacarbazine, 100 mg
Code added date: 19860101.
Code effective date: 20040101.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF

J9144 - Daratumumab, hyaluronidase
Long description: Injection, daratumumab, 10 mg and hyaluronidase-fihj
Code added date: 20210101.
Code effective date: 20210101.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: C (A code denoting Medicare coverage status).
HTML    PDF

J9145 - Injection, daratumumab 10 mg
Long description: Injection, daratumumab, 10 mg
Code added date: 20170101.
Code effective date: 20170101.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF

J9150 - Daunorubicin injection
Long description: Injection, daunorubicin, 10 mg
Code added date: 19860101.
Code effective date: 20090101.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF

J9151 - Daunorubicin citrate inj
Long description: Injection, daunorubicin citrate, liposomal formulation, 10 mg
Code added date: 19990101.
Code effective date: 20260101.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF

J9153 - Inj daunorubicin, cytarabine
Long description: Injection, liposomal, 1 mg daunorubicin and 2.27 mg cytarabine
Code added date: 20190101.
Code effective date: 20190101.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: C (A code denoting Medicare coverage status).
HTML    PDF